About ACGT


Support AGCT - Donate Now 		Financial Reports

Alliance for Cancer Gene Therapy, Inc.’s complete audited financial statements are available upon request.

View ACGT's IRS Form 990 for 2008 in PDF format.

Condensed Statements of Activities 2009   2008  
 
Support and revenue:
    Contributions $514,503   $3,216,189  
    Contributions for administrative expenses
    (specially designated)		 1,043,641   207,622  
    Contributed services 368,838   277,994  
    Interest and dividend income 73,218   163,562  
    Realized and unrealized gains on investments, net (1,698,681)   32,396  
         
    TOTAL SUPPORT AND REVENUE 301,519   3,897,763  
 
Expenses:
   Program services:
        Research grants and awards 678,901   3,351,997  
   Management and general 1,331,183   373,331  
   Fundraising 40,651   45,719  
    TOTAL EXPENSES 2,050,735   3,771,047  
         
    Increase in total net assets (1,749,216)   126,716  
    Total net assets at beginning of year 2,395,991   2,269,275  
         
TOTAL NET ASSETS AT END OF YEAR $646,775   $2,395,991  
         
         
Condensed Statements of Financial Position 2009   2008  
 
Assets:
    Cash and cash equivalents $979,202   $3,668,183  
    Contributions receivable and accounts receivable, net 329,268   1,730,669  
    Investments, at fair value 2,703,254   3,173,439  
    TOTAL ASSETS 4,011,724   8,572,291  
 
Liabilities and net assets:
Liabilities:
    Grants payable $3,337,921   $6,151,248  
    Accounts payable and accrued expenses 27,028   25,052  
    TOTAL LIABILITIES 3,364,949   6,176,300  
         
    TOTAL NET ASSETS 646,775   2,395,991  
         
TOTAL LIABILITIES AND NET ASSETS $4,011,724   $8,572,291  
 
Home   |   About ACGT   |   Contact ACGT   |   Site Contents   |   Privacy Policy

©2010 Alliance for Cancer Gene Therapy  96 Cummings Point Road, Stamford, CT, 06902